Constitutive Expression of the Adenovirus E3-14.7K Protein Does Not Prolong Adenovirus Vector DNA Persistence but Protects Mice Against Lipopolysaccharide-Induced Acute Hepatitis
- 20 May 2002
- journal article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 13 (8) , 921-933
- https://doi.org/10.1089/10430340252939032
Abstract
First-generation adenovirus vectors, deleted in the E1 and E3 regions of the genome, induce a strong inflammatory response that affects persistence of vector DNA in transduced organs and causes toxicity in the host. Wild-type adenovirus encodes a number of proteins that are nonessential for viral propagation in vitro but that dampen the inflammatory and immune responses mounted by the host during infection. The adenovirus E3 region-encoded 14.7K protein inhibits tumor necrosis factor alpha (TNF-alpha)-induced apoptosis and arachidonic acid synthesis. To evaluate the impact of constitutive expression of the 14.7K protein on vector-induced pathology, toxicity, and DNA persistence, we constructed vectors that contain a cytomegalovirus promoter-driven 14.7K expression cassette. Although these vectors inhibit TNF-alpha-induced apoptosis in vitro, they do not show better vector DNA persistence, or lower inflammation or pathology than E3-deleted first-generation vector in mouse models. However, the 14.7K protein is functional in mice because animals injected intravenously with a 14.7K-constitutive vector were fully protected against a lethal dose of lipopolysaccharide 5 days after vector administration. These results open new applications for the E3-encoded 14.7K protein, which can be used to protect organs against inflammatory reactions and TNF-alpha-mediated apoptosis.Keywords
This publication has 51 references indexed in Scilit:
- Liver regenerationJournal of Hepatology, 2000
- Adenoviral Gene Therapy Leads to Rapid Induction of Multiple Chemokines and Acute Neutrophil-Dependent Hepatic Injury in VivoHuman Gene Therapy, 1999
- Nonspecific Inflammation Inhibits Adenovirus-Mediated Pulmonary Gene Transfer and Expression Independent of Specific Acquired Immune ResponsesHuman Gene Therapy, 1998
- Lung-Specific Expression of Adenovirus E3-14.7K in Transgenic Mice Attenuates Adenoviral Vector-Mediated Lung Inflammation and Enhances Transgene ExpressionHuman Gene Therapy, 1998
- Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administrationGene Therapy, 1998
- Mediators of inflammationCurrent Opinion in Immunology, 1997
- Molecules involved in cell death and peripheral toleranceCurrent Opinion in Immunology, 1997
- Role of Alveolar Macrophages in Rapid Elimination of Adenovirus Vectors Administered to the Epithelial Surface of the Respiratory TractHuman Gene Therapy, 1997
- Gene therapy: adenovirus vectorsCurrent Opinion in Genetics & Development, 1993
- The Pathophysiology of Tumor Necrosis FactorsAnnual Review of Immunology, 1992